Pembrolizumab/quavonlimab coformulation in combination with lenvatinib in advanced hepatocellular carcinoma: Phase 2 trial in progress

Li, D; Cheng, A; Lim, H; Llovet, J; Zhu, Y; Hatogai, K; Siegel, A; Kudo, M

ANNALS OF ONCOLOGY, 2021; 32 (): S144